Written Question·Department of Health and Social Care·UIN 94611
Rare Diseases: Drugs
Tabled: 25 November 2025
Answered: 1 December 2025
Question
Mr Joshua Reynolds
Liberal Democrat — Maidenhead
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the suitability of the National Institute for Health and Care Excellence’s approach to evaluating the cost-effectiveness of rare disease medicines.
Answer
Dr Zubir AhmedThe National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based recommendations for the National Health Service on whether new medicines represent a clinically and cost-effectiv...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 94611) →